Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway.

Hara M, Takeba Y, Iiri T, Ohta Y, Ootaki M, Watanabe M, Watanabe D, Koizumi S, Otsubo T, Matsumoto N.

Cancer Sci. 2019 Jan;110(1):235-244. doi: 10.1111/cas.13861. Epub 2018 Dec 4.

2.

Downregulation of USP18 inhibits growth and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma cells by suppressing BCL2L1.

Cai J, Liu T, Jiang X, Guo C, Liu A, Xiao X.

Exp Cell Res. 2017 Sep 15;358(2):315-322. doi: 10.1016/j.yexcr.2017.07.006. Epub 2017 Jul 12.

PMID:
28709980
3.

A phosphokinome-based screen uncovers new drug synergies for cancer driven by liver-specific gain of nononcogenic receptor tyrosine kinases.

Fan Y, Arechederra M, Richelme S, Daian F, Novello C, Calderaro J, Di Tommaso L, Morcrette G, Rebouissou S, Donadon M, Morenghi E, Zucman-Rossi J, Roncalli M, Dono R, Maina F.

Hepatology. 2017 Nov;66(5):1644-1661. doi: 10.1002/hep.29304. Epub 2017 Sep 29.

PMID:
28586114
4.

Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.

Fujii Y, Segawa R, Kimura M, Wang L, Ishii Y, Yamamoto R, Morita R, Mitsumori K, Shibutani M.

Chem Biol Interact. 2013 Sep 25;205(2):108-18. doi: 10.1016/j.cbi.2013.06.017. Epub 2013 Jul 2.

PMID:
23830814
5.

[Anionic long circulation liposomes mediated antisense scintigraphy in tumor-bearing rats].

Ma C, Kuang A, Huang R, Tang G.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011 Apr;28(2):233-7. Chinese.

PMID:
21604475
6.

Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III.

Jiang H, Wang H, Tan Z, Hu S, Wang H, Shi B, Yang L, Li P, Gu J, Wang H, Li Z.

J Biol Chem. 2011 Feb 18;286(7):5913-20. doi: 10.1074/jbc.M110.192252. Epub 2010 Dec 16.

7.

Divergent pathways for TNF and C(2)-ceramide toxicity in HTC hepatoma cells.

Autelli R, Ullio C, Prigione E, Crepaldi S, Schiavone N, Brunk UT, Capaccioli S, Baccino FM, Bonelli G.

Biochim Biophys Acta. 2009 Jul;1793(7):1182-90. doi: 10.1016/j.bbamcr.2009.03.005. Epub 2009 Mar 25.

8.

Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.

Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Thng CH, Chow P, Ong HS, Chung A, Soo KC.

J Cell Mol Med. 2009 Aug;13(8B):2673-83. doi: 10.1111/j.1582-4934.2009.00692.x. Epub 2009 Feb 9.

9.

Multiple organ failure of tumor-bearing rabbits in cancer cachexia is caused by apoptosis of normal organ cells.

Fukuda T, Sumi T, Nobeyama H, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.

Int J Oncol. 2009 Jan;34(1):61-7.

PMID:
19082478
10.

Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.

Lau CK, Yang ZF, Lam SP, Lam CT, Ngai P, Tam KH, Poon RT, Fan ST.

Cancer Biol Ther. 2007 Dec;6(12):1900-7. Epub 2007 Sep 1.

PMID:
18059167
11.

Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.

Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.

Biochem Pharmacol. 2007 Dec 3;74(11):1575-86. Epub 2007 Aug 11.

PMID:
17869226
12.

Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.

Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E.

Gastroenterology. 2007 Mar;132(3):1088-103. Epub 2006 Dec 19.

PMID:
17383430
13.

Time-dependent onset of Interferon-alpha2b-induced apoptosis in isolated hepatocytes from preneoplastic rat livers.

Alvarez Mde L, Quiroga AD, Ronco MT, Parody JP, Ochoa JE, Monti JA, Carnovale CE, Carrillo MC.

Cytokine. 2006 Dec;36(5-6):245-53. Epub 2007 Mar 21.

PMID:
17376698
14.
16.

Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.

Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.

Clin Cancer Res. 2005 Feb 1;11(3):1277-86.

17.

Enhancement of tumor response by farnesyltransferase inhibitor in C3H/HeJ hepatocarcinoma.

Kim J, Seong J, Kim SH.

Ann N Y Acad Sci. 2004 Dec;1030:95-102.

PMID:
15659785
18.

Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.

Sutter AP, Maaser K, Grabowski P, Bradacs G, Vormbrock K, Höpfner M, Krahn A, Heine B, Stein H, Somasundaram R, Schuppan D, Zeitz M, Scherübl H.

J Hepatol. 2004 Nov;41(5):799-807.

PMID:
15519653
19.

Regulation of alpha-fetoprotein by nuclear factor-kappaB protects hepatocytes from tumor necrosis factor-alpha cytotoxicity during fetal liver development and hepatic oncogenesis.

Cavin LG, Venkatraman M, Factor VM, Kaur S, Schroeder I, Mercurio F, Beg AA, Thorgeirsson SS, Arsura M.

Cancer Res. 2004 Oct 1;64(19):7030-8.

Supplemental Content

Loading ...
Support Center